Homologous Sequential Immunization Using Salmonella Oral Administration Followed by an Intranasal Boost with Ferritin-Based Nanoparticles Enhanced the Humoral Immune Response against H1N1 Influenza Virus
ABSTRACT The influenza virus continues to pose a great threat to public health due to the frequent variations in RNA viruses. Vaccines targeting conserved epitopes, such as the extracellular domain of the transmembrane protein M2 (M2e), a nucleoprotein, and the stem region of hemagglutinin proteins,...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2023-06-01
|
| Series: | Microbiology Spectrum |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/spectrum.00102-23 |
| _version_ | 1797803419333820416 |
|---|---|
| author | Zhannan Wang Tongyu Zhang Futing Jia Chongbo Ge Yingkai He Yawen Tian Wenfeng Wang Guilian Yang Haibin Huang Jianzhong Wang Chunwei Shi Wentao Yang Xin Cao Yan Zeng Nan Wang Aidong Qian Chunfeng Wang Yanlong Jiang |
| author_facet | Zhannan Wang Tongyu Zhang Futing Jia Chongbo Ge Yingkai He Yawen Tian Wenfeng Wang Guilian Yang Haibin Huang Jianzhong Wang Chunwei Shi Wentao Yang Xin Cao Yan Zeng Nan Wang Aidong Qian Chunfeng Wang Yanlong Jiang |
| author_sort | Zhannan Wang |
| collection | DOAJ |
| description | ABSTRACT The influenza virus continues to pose a great threat to public health due to the frequent variations in RNA viruses. Vaccines targeting conserved epitopes, such as the extracellular domain of the transmembrane protein M2 (M2e), a nucleoprotein, and the stem region of hemagglutinin proteins, have been developed, but more efficient strategies, such as nanoparticle-based vaccines, are still urgently needed. However, the labor-intensive in vitro purification of nanoparticles is still necessary, which could hinder the application of nanoparticles in the veterinary field in the future. To overcome this limitation, we used regulated lysis Salmonella as an oral vector with which to deliver three copies of M2e (3M2e-H1N1)-ferritin nanoparticles in situ and evaluated the immune response. Then, sequential immunization using Salmonella-delivered nanoparticles followed by an intranasal boost with purified nanoparticles was performed to further improve the efficiency. Compared with 3M2e monomer administration, Salmonella-delivered in situ nanoparticles significantly increased the cellular immune response. Additionally, the results of sequential immunization showed that the intranasal boost with purified nanoparticles dramatically stimulated the activation of lung CD11b dendritic cells (DCs) and elevated the levels of effector memory T (TEM) cells in both spleen and lung tissues as well as those of CD4 and CD8 tissue-resident memory T (TRM) cells in the lungs. The increased production of mucosal IgG and IgA antibody titers was also observed, resulting in further improvements to protection against a virus challenge, compared with the pure oral immunization group. Salmonella-delivered in situ nanoparticles efficiently increased the cellular immune response, compared with the monomer, and sequential immunization further improved the systemic immune response, as shown by the activation of DCs, the production of TEM cells and TRM cells, and the mucosal immune response, thereby providing us with a novel strategy by which to apply nanoparticle-based vaccines in the future. IMPORTANCE Salmonella-delivered in situ nanoparticle platforms may provide novel nanoparticle vaccines for oral administration, which would be beneficial for veterinary applications. The combination of administering Salmonella-vectored, self-assembled nanoparticles and an intranasal boost with purified nanoparticles significantly increased the production of effector memory T cells and lung resident memory T cells, thereby providing partial protection against an influenza virus challenge. This novel strategy could open a novel avenue for the application of nanoparticle vaccines for veterinary purposes. |
| first_indexed | 2024-03-13T05:20:31Z |
| format | Article |
| id | doaj.art-c8d6c859ae5a49d28734781eca04b7e1 |
| institution | Directory Open Access Journal |
| issn | 2165-0497 |
| language | English |
| last_indexed | 2024-03-13T05:20:31Z |
| publishDate | 2023-06-01 |
| publisher | American Society for Microbiology |
| record_format | Article |
| series | Microbiology Spectrum |
| spelling | doaj.art-c8d6c859ae5a49d28734781eca04b7e12023-06-15T13:18:33ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972023-06-0111310.1128/spectrum.00102-23Homologous Sequential Immunization Using Salmonella Oral Administration Followed by an Intranasal Boost with Ferritin-Based Nanoparticles Enhanced the Humoral Immune Response against H1N1 Influenza VirusZhannan Wang0Tongyu Zhang1Futing Jia2Chongbo Ge3Yingkai He4Yawen Tian5Wenfeng Wang6Guilian Yang7Haibin Huang8Jianzhong Wang9Chunwei Shi10Wentao Yang11Xin Cao12Yan Zeng13Nan Wang14Aidong Qian15Chunfeng Wang16Yanlong Jiang17College of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaCollege of Animal Medicine, Jilin Provincial Engineering Research Center of Animal Probiotics, Jilin Provincial Key Laboratory of Animal Microecology and Healthy Breeding, Engineering Research Center of Microecological Vaccines (Drugs) for Major Animal Diseases, Ministry of Education, Jilin Agricultural University, Changchun, ChinaABSTRACT The influenza virus continues to pose a great threat to public health due to the frequent variations in RNA viruses. Vaccines targeting conserved epitopes, such as the extracellular domain of the transmembrane protein M2 (M2e), a nucleoprotein, and the stem region of hemagglutinin proteins, have been developed, but more efficient strategies, such as nanoparticle-based vaccines, are still urgently needed. However, the labor-intensive in vitro purification of nanoparticles is still necessary, which could hinder the application of nanoparticles in the veterinary field in the future. To overcome this limitation, we used regulated lysis Salmonella as an oral vector with which to deliver three copies of M2e (3M2e-H1N1)-ferritin nanoparticles in situ and evaluated the immune response. Then, sequential immunization using Salmonella-delivered nanoparticles followed by an intranasal boost with purified nanoparticles was performed to further improve the efficiency. Compared with 3M2e monomer administration, Salmonella-delivered in situ nanoparticles significantly increased the cellular immune response. Additionally, the results of sequential immunization showed that the intranasal boost with purified nanoparticles dramatically stimulated the activation of lung CD11b dendritic cells (DCs) and elevated the levels of effector memory T (TEM) cells in both spleen and lung tissues as well as those of CD4 and CD8 tissue-resident memory T (TRM) cells in the lungs. The increased production of mucosal IgG and IgA antibody titers was also observed, resulting in further improvements to protection against a virus challenge, compared with the pure oral immunization group. Salmonella-delivered in situ nanoparticles efficiently increased the cellular immune response, compared with the monomer, and sequential immunization further improved the systemic immune response, as shown by the activation of DCs, the production of TEM cells and TRM cells, and the mucosal immune response, thereby providing us with a novel strategy by which to apply nanoparticle-based vaccines in the future. IMPORTANCE Salmonella-delivered in situ nanoparticle platforms may provide novel nanoparticle vaccines for oral administration, which would be beneficial for veterinary applications. The combination of administering Salmonella-vectored, self-assembled nanoparticles and an intranasal boost with purified nanoparticles significantly increased the production of effector memory T cells and lung resident memory T cells, thereby providing partial protection against an influenza virus challenge. This novel strategy could open a novel avenue for the application of nanoparticle vaccines for veterinary purposes.https://journals.asm.org/doi/10.1128/spectrum.00102-23influenza virusnanoparticle vaccineSalmonellain situsequential immunizationTRM cell |
| spellingShingle | Zhannan Wang Tongyu Zhang Futing Jia Chongbo Ge Yingkai He Yawen Tian Wenfeng Wang Guilian Yang Haibin Huang Jianzhong Wang Chunwei Shi Wentao Yang Xin Cao Yan Zeng Nan Wang Aidong Qian Chunfeng Wang Yanlong Jiang Homologous Sequential Immunization Using Salmonella Oral Administration Followed by an Intranasal Boost with Ferritin-Based Nanoparticles Enhanced the Humoral Immune Response against H1N1 Influenza Virus Microbiology Spectrum influenza virus nanoparticle vaccine Salmonella in situ sequential immunization TRM cell |
| title | Homologous Sequential Immunization Using Salmonella Oral Administration Followed by an Intranasal Boost with Ferritin-Based Nanoparticles Enhanced the Humoral Immune Response against H1N1 Influenza Virus |
| title_full | Homologous Sequential Immunization Using Salmonella Oral Administration Followed by an Intranasal Boost with Ferritin-Based Nanoparticles Enhanced the Humoral Immune Response against H1N1 Influenza Virus |
| title_fullStr | Homologous Sequential Immunization Using Salmonella Oral Administration Followed by an Intranasal Boost with Ferritin-Based Nanoparticles Enhanced the Humoral Immune Response against H1N1 Influenza Virus |
| title_full_unstemmed | Homologous Sequential Immunization Using Salmonella Oral Administration Followed by an Intranasal Boost with Ferritin-Based Nanoparticles Enhanced the Humoral Immune Response against H1N1 Influenza Virus |
| title_short | Homologous Sequential Immunization Using Salmonella Oral Administration Followed by an Intranasal Boost with Ferritin-Based Nanoparticles Enhanced the Humoral Immune Response against H1N1 Influenza Virus |
| title_sort | homologous sequential immunization using salmonella oral administration followed by an intranasal boost with ferritin based nanoparticles enhanced the humoral immune response against h1n1 influenza virus |
| topic | influenza virus nanoparticle vaccine Salmonella in situ sequential immunization TRM cell |
| url | https://journals.asm.org/doi/10.1128/spectrum.00102-23 |
| work_keys_str_mv | AT zhannanwang homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT tongyuzhang homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT futingjia homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT chongboge homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT yingkaihe homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT yawentian homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT wenfengwang homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT guilianyang homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT haibinhuang homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT jianzhongwang homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT chunweishi homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT wentaoyang homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT xincao homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT yanzeng homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT nanwang homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT aidongqian homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT chunfengwang homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus AT yanlongjiang homologoussequentialimmunizationusingsalmonellaoraladministrationfollowedbyanintranasalboostwithferritinbasednanoparticlesenhancedthehumoralimmuneresponseagainsth1n1influenzavirus |